AMPHOTERICIN B
ANTIFUNGALS-SYSTEMIC·FUNGAL SEPSIS·+22
X-GEN PHARMACEU
Indication
Pulmonary cryptococcosis
Pulmonary cryptococcosis is an invasive fungal infection of the respiratory tract caused by the inhalation of environmental basidiospores or desiccated yeast cells, most commonly from the *Cryptococcus neoformans* or *Cryptococcus gattii* species complexes. Read more about Pulmonary cryptococcosis
3 drugs 3 manufacturers
Drugs that treat it
Common Pulmonary cryptococcosis therapies.
ABELCET (amphotericin B lipid complex)
FUNGAL SEPSIS·+22
SIGMA-TAU
ABELCET (amphotericin B lipid complex)
FUNGAL SEPSIS·+22
SIGMA-TAU/LEADI
Filter & compare in the drug finder →Opens the drug finder with Pulmonary cryptococcosis preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonPulmonary cryptococcosis is an invasive fungal infection of the respiratory tract caused by the inhalation of environmental basidiospores or desiccated yeast cells, most commonly from the *Cryptococcus neoformans* or *Cryptococcus gattii* species complexes.
While it primarily affects immunocompromised individuals—notably those with advanced HIV disease, solid organ transplants, or prolonged immunosuppressive therapy—it can also develop in immunocompetent hosts.
The clinical spectrum ranges from asymptomatic localized colonization to subacute or acute pneumonia, with symptoms including cough, dyspnea, pleuritic chest pain, and fever.
Pathophysiologically characterized by granulomatous or tissue-invasive inflammation, the infection typically manifests radiographically as solitary or multiple pulmonary nodules, cryptococcomas, consolidations, or cavitary lesions, carrying a significant risk of hematogenous dissemination to the central nervous system.
- nih.gov
Pulmonary cryptococcosis is an invasive fungal infection of the respiratory tract caused by the inhalation of environmental basidiospores or desiccated yeast cells, most commonly from the *Cryptococcus neoformans* or *Cryptococcus gattii* species complexes Pathophysiologically characterized by granulomatous or tissue-invasive inflammation, the infection typically manifests radiographically as solitary or multiple pulmonary nodules, cryptococcomas, consolidations, or cavitary lesions, carrying a ...
- cdc.gov
Pulmonary cryptococcosis is an invasive fungal infection of the respiratory tract caused by the inhalation of environmental basidiospores or desiccated yeast cells, most commonly from the *Cryptococcus neoformans* or *Cryptococcus gattii* species complexes The clinical spectrum ranges from asymptomatic localized colonization to subacute or acute pneumonia, with symptoms including cough, dyspnea, pleuritic chest pain, and fever
- cdc.gov
While it primarily affects immunocompromised individuals—notably those with advanced HIV disease, solid organ transplants, or prolonged immunosuppressive therapy—it can also develop in immunocompetent hosts
- nih.gov
While it primarily affects immunocompromised individuals—notably those with advanced HIV disease, solid organ transplants, or prolonged immunosuppressive therapy—it can also develop in immunocompetent hosts
- nih.gov
The clinical spectrum ranges from asymptomatic localized colonization to subacute or acute pneumonia, with symptoms including cough, dyspnea, pleuritic chest pain, and fever Pathophysiologically characterized by granulomatous or tissue-invasive inflammation, the infection typically manifests radiographically as solitary or multiple pulmonary nodules, cryptococcomas, consolidations, or cavitary lesions, carrying a significant risk of hematogenous dissemination to the central nervous system
- nih.gov
Pathophysiologically characterized by granulomatous or tissue-invasive inflammation, the infection typically manifests radiographically as solitary or multiple pulmonary nodules, cryptococcomas, consolidations, or cavitary lesions, carrying a significant risk of hematogenous dissemination to the central nervous system
Personalize your experience
Follow Pulmonary cryptococcosis and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.